Jagsonpal Pharmaceuticals (JAGSNPHARM) — Corporate Action

📢 Key Event
Allotment of 94,000 shares under ESOP 2022

🔄 What Changed
Paid-up capital rose to Rs. 13,18,58,940; shares increased to 6,59,29,470

🔮 What's Next
NA

💡 Investor Takeaway
The ESOP issuance expands share count and capital without altering shareholder rights.

Jagsonpal Pharmaceuticals announced the allotment of 94,000 equity shares of Rs. 2 each under its Employee Stock Option Plan 2022, increasing paid-up capital from Rs. 13,16,70,940 to Rs. 13,18,58,940 and total shares from 6,58,35,470 to 6,59,29,470, effective July 15, 2026.

📄 View Original Announcement (PDF)

📊 Stock Analysis — JAGSNPHARM ✨ Ask AI About This

About Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,586.96 Cr P/E: 35.5 ROE: 19.0% ROCE: 25.8% Div Yield: 1.66%

View full JAGSNPHARM stock details →

📡 Get AI alerts when JAGSNPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track JAGSNPHARM — Free

💡 Ask AI about this filing

"How does this ESOP dilution affect EPS?" "What is the current market price of JAGSNPHARM?" "When do the exercised options expire?"

Ask AI Free →

📊 More JAGSNPHARM filings

See all JAGSNPHARM filings →

🔥 Also filed on 15 July 2026

DYCL Dynamic Cables Limited Financial Results J&KBANK The Jammu & Kashmir Bank Limited Announcement VIMTALABS Vimta Labs Limited Financial Results RELTD Ravindra Energy Limited Offer Document RAMKY Ramky Infrastructure Limited Insider Trading KALAMANDIR Sai Silks (Kalamandir) Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when JAGSNPHARM files new disclosures

Track JAGSNPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track JAGSNPHARM — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd